Company Filing History:
3 out of 3 
1 out of 2 
1 out of 1 Years Active: 1996-2022
Title: Innovations and Contributions of Jose Ignacio Casal Alvarez
Introduction
Jose Ignacio Casal Alvarez is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of peptides and viral structures for medical applications. With a total of 7 patents, his work has the potential to impact treatments for various diseases.
Latest Patents
One of his latest patents is titled "IL13Rα2 peptide and its uses." This invention relates to a peptide that comprises the amino acid sequence SEQ ID NO: 1 or a variant capable of inhibiting IL13/IL13Rα2 signaling. The invention also includes a fusion protein, nanoparticle, virus-like particle, and pharmaceutical composition that incorporates this peptide. These innovations are aimed at treating cancers characterized by increased expression of IL13Rα2, as well as conditions such as asthma, atopic dermatitis, and fibrosis. Another notable patent is "Icosahedral superstructure of VP2 of infectious bursitis virus (IBDV) and the application thereof." This patent describes IBDV VP2 icosahedral superstructures composed of 12 empty VP2 dodecahedral capsids, which lack genetic material. These structures, measuring approximately 60–68 nm in diameter and containing 720 IBDV VP2 subunits, can be utilized for vaccination and diagnostic purposes.
Career Highlights
Throughout his career, Jose Ignacio has worked with several notable companies, including Inmunología y Genética Aplicada, S.A. and Cyanamid Ibérica, S.A. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.
Collaborations
Jose Ignacio has collaborated with several professionals in his field, including Carmen Vela Olmo and Kristian Dalsgaard. These partnerships have likely enhanced his research and innovation capabilities.
Conclusion
Jose Ignacio Casal Alvarez is a distinguished inventor whose work in biotechnology has led to significant advancements in medical treatments. His patents reflect a commitment to addressing critical health issues through innovative solutions.